Lipopolysaccharide plus 12-o-tetradecanoylphorbol 13-acetate induction of migration and invasion of glioma cells in vitro and in vivo: Differential inhibitory effects of flavonoids

Neuroscience

Volumn 140, Issue 2, 2006, Pages 477-489

  Shen, S C ^a,b   Lin, C W ^c   Lee, H M ^c   Chien, L L ^c   Chen, Y C ^c  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

flavonoids; invasion; LPS; migration; MMP 9; TPA

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; AURANTIIN; BAICALEIN; FISETIN; FLAVONE; FLAVONOID; INDUCIBLE NITRIC OXIDE SYNTHASE; KAEMPFEROL; LIPOPOLYSACCHARIDE; METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; MORIN; MYRICETIN; NITRIC OXIDE; PHORBOL 13 ACETATE 12 MYRISTATE; QUERCETIN; STRESS ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; TAXIFOLIN; WOGONIN;

ANIMAL CELL; ARTICLE; CELL INVASION; CELL MIGRATION; CELL TRANSFORMATION; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME IMMOBILIZATION; ENZYME REGULATION; GENE EXPRESSION; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; STATISTICAL SIGNIFICANCE;

ANIMALS; ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; CARCINOGENS; CELL MOVEMENT; CELL TRANSFORMATION, NEOPLASTIC; DRUG SYNERGISM; ENZYME ACTIVATION; ENZYME INHIBITORS; FLAVANONES; FLAVONOIDS; GLIOMA; HUMANS; KAEMPFEROLS; LIPOPOLYSACCHARIDES; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RATS; TETRADECANOYLPHORBOL ACETATE;

EID: 33646520821     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2006.02.028     Document Type: Article

References (41)

1. Altuwaijri S., Lin H.K., Chuang K.H., Lin W.J., Yeh S., Hanchett L.A., Rahman M.M., Kang H.Y., Tsai M.Y., Zhang Y., Yang L., and Chang C. Interruption of nuclear factor kappaB signaling by the androgen receptor facilitates 12-O-tetradecanoylphorbolacetate-induced apoptosis in androgen-sensitive prostate cancer LNCaP cells. Cancer Res 63 (2003) 7106-7112
2. Baramova E., and Foidart J.M. Matrix metalloproteinase family. Cell Biol Int 19 (1995) 239-242
3. Billiar T.R. Nitric oxide. Novel biology with clinical relevance. Ann Surg 221 (1995) 339-349
4. Brown J.E., Khodr H., Hider R.C., and Rice-Evans C.A. Structural dependence of flavonoid interactions with Cu2+ ions. implications for their antioxidant properties. Biochem J 330 (1998) 1173-1178
5. Brusselmans K., Vrolix R., Verhoeven G., and Swinnen J.V. Induction of cancer cell apoptosis by flavonoids is associated with their ability to inhibit fatty acid synthase activity. J Biol Chem 280 (2005) 5636-5645
6. Chang M.S., Chen B.C., Yu M.T., Sheu J.R., Chen T.F., and Lin C.H. Phorbol 12-myristate 13-acetate upregulates cyclooxygenase-2 expression in human pulmonary epithelial cells via Ras, Raf-1, ERK, and NF-kappaB, but not p38 MAPK, pathways. Cell Signal 17 (2005) 299-310
7. Chen T.J., Shen S.C., Lin H.Y., Chien L.L., and Chen Y.C. Lipopolysaccharide enhancement of 12-o-tetradecanoylphorbol 13-acetate-mediated transformation in rat glioma C6, accompanied by induction of inducible nitric oxide synthase. Toxicol Lett 147 (2004) 1-13
8. Chen Y.C., Shen S.C., Chen L.G., Lee T.J.F., and Yang L.L. Wogonin, baicalin, and baicalein inhibition of inducible nitric oxide synthase and cyclooxygenase 2 gene expressions induced by NOS inhibitors and lipopolysaccharide. Biochem Pharmacol 61 (2001) 1417-1427
9. Chen Y.C., Shen S.C., Chow J.M., Ko C.H., and Tseng S.W. Flavone inhibition of tumor growth via apoptosis in vitro and in vivo. Int J Oncol 25 (2004) 661-670
10. Chen Y.C., Shen S.C., and Tsai S.H. Prostaglandin D(2) and J(2) induce apoptosis in human leukemia cells via activation of the caspase 3 cascade and production of reactive oxygen species. Biochim Biophys Acta 1743 (2005) 291-304
11. Cho J., and Lee H.K. Wogonin inhibits excitotoxic and oxidative neuronal damage in primary cultured rat cortical cells. Eur J Pharmacol 485 (2004) 105-110
12. Crawford H.C., and Matrisian L.M. Tumor and stromal expression of matrix metalloproteinases and their role in tumor progression. Invasion Metastasis 14 (1995) 234-245
13. Dong Z., Staroselsky A.H., Qi X., Xie K., and Fidler I.J. Inverse correlation between expression of inducible nitric oxide synthase activity and production of metastasis in K-1735 murine melanoma cells. Cancer Res 54 (1994) 789-793
14. Edwards P., Cendan J.C., Topping D.B., Moldawer L.L., MacKay S., Copeland E.M., and Lind D.S. Tumor cell nitric oxide inhibits cell growth in vitro, but stimulates tumorigenesis and experimental lung metastasis in vivo. J Surg Res 63 (1996) 49-52
15. Engedal N., Korkmaz C.G., and Saatcioglu F. C-Jun N-terminal kinase is required for phorbol ester- and thapsigargin-induced apoptosis in the androgen responsive prostate cancer cell line LNCaP. Oncogene 21 (2002) 1017-1027
16. Feinstein D.L., and Reis D.J. Regunathan S. Inhibition of astroglial nitric oxide synthase type 2 expression by idazoxan. Mol Pharmacol 55 (1999) 304-308
17. Giese A., and Westphal M. Glioma invasion in the central nervous system. Neurosurgery 39 (1996) 235-250
18. Giese A., Kluwe L., Laube B., Meissner H., Berens M.E., and Westphal M. Migration of human glioma cells on myelin. Neurosurgery 38 (1996) 755-764
19. Han Z.T., Zhu X.X., Yang R.Y., Sun J.Z., Tian G.F., Liu X.J., Cao G.S., Newmark H.L., Conney A.H., and Chang R.L. Effect of intravenous infusions of 12-O-tetradecanoylphorbol-13-acetate (TPA) in patients with myelocytic leukemia. preliminary studies on therapeutic efficacy and toxicity. Proc Natl Acad Sci U S A 95 (1998) 5357-5361
20. Ko C.H., Shen S.C., Lee T.J., and Chen Y.C. Myricetin inhibits matrix metalloproteinase 2 protein expression and enzyme activity in colorectal carcinoma cells. Mol Cancer Ther 4 (2005) 281-290
21. Ko C.H., Shen S.C., Lin H.Y., Hou W.C., Lee W.R., Yang L.L., and Chen Y.C. Flavanones structure-related inhibition on TPA-induced tumor promotion through suppression of extracellular signal-regulated protein kinases. involvement of prostaglandin E2 in anti-promotive process. J Cell Physiol 193 (2002) 93-102
22. Lin H.Y., Juan S.H., Shen S.C., Hsu F.L., and Chen Y.C. Inhibition of lipopolysaccharide-induced nitric oxide production by flavonoids in RAW264.7 macrophages involves heme oxygenase-1. Biochem Pharmacol 66 (2003) 1821-1832
23. Lin H.Y., Shen S.C., and Chen Y.C. Anti-inflammatory effect of heme oxygenase 1. glycosylation and nitric oxide inhibition in macrophages. J Cell Physiol 202 (2005) 579-590
24. Liotta L. The role of cellular proteases and their inhibitors in invasion and metastasis. Introductionary overview. Cancer Metastasis Rev 9 (1990) 285-287
25. Lopez-Gonzalez M.A., and Sotelo J. Brain tumors in Mexico. characteristics and prognosis of glioblastoma. Surg Neurol 53 (2000) 157-162
26. Militante J.D., Feinstein D.L., and Syapin P.J. Suppression by ethanol of inducible nitric oxide synthase expression in C6 glioma cells. J Pharmacol Exp Ther 281 (1997) 558-565
27. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J 6 (1992) 3051-3064
28. Noroozi M., Angerson W.J., and Lean M.E. Effects of flavonoids and vitamin C on oxidative DNA damage to human lymphocytes. Am J Clin Nutr 67 (1998) 1210-1218
29. Palmer R.M., Ferrige A.G., and Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327 (1987) 524-526
30. Park M.J., Park I.C., Hur J.H., Rhee C.H., Choe T.B., Yi D.H., Hong S.I., and Lee S.H. Protein kinase C activation by phorbol ester increases in vitro invasion through regulation of matrix metalloproteinases/tissue inhibitors of metalloproteinases system in D54 human glioblastoma cells. Neurosci Lett 290 (2000) 201-204
31. Ren L.Q., Garrett D.K., Syapin M., and Syapin P.J. Differential fibronectin expression in activated C6 glial cells treated with ethanol. Mol Pharmacol 58 (2000) 1303-1309
32. Samhan-Arias A.K., Martin-Romero F.J., and Gutierrez-Merino C. Kaempferol blocks oxidative stress in cerebellar granule cells and reveals a key role for reactive oxygen species production at the plasma membrane in the commitment to apoptosis. Free Radic Biol Med 37 (2004) 48-61
33. Shen S.C., Ko C.H., Hsu K.C., and Chen Y.C. 3-OH flavone inhibition of epidermal growth factor-induced proliferation through blocking prostaglandin E2 production. Int J Cancer 108 (2004) 502-510
34. Shen S.C., Ko C.H., Tseng S.W., and Chen Y.C. Structurally-related anti-tumor effects of flavanones in vitro and in vivo. involvement of caspase 3 activation, p21 gene expression and reactive oxygen species production. Toxicol Appl Pharmacol 197 (2004) 84-95
35. Shi Q., Xiong Q., Wang B., Le X., Khan N.A., and Xie K. Influence of nitric oxide synthase II gene disruption on tumor growth and metastasis. Cancer Res 60 (2000) 2579-2583
36. Simpson J.R., Horton J., Scott C., Curran W.J., Rubin P., Fischbach J., Isaacson S., Rotman M., Asbell S.O., Nelson J.S., et al. Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme. results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials. Int J Radiat Oncol Biol Phys 26 (1993) 239-244
37. Wang B., Wei D., Crum V.E., Richardson E.L., Xiong H.H., Luo Y., Huang S., Abbruzzese J.L., and Xie K. A novel model system for studying the double-edged roles of nitric oxide production in pancreatic cancer growth and metastasis. Oncogene 22 (2003) 1771-1782
38. Wei D., Richardson E.L., Zhu K., Wang L., Le X., He Y., Huang S., and Xie K. Direct demonstration of negative regulation of tumor growth and metastasis by host-inducible nitric oxide synthase. Cancer Res 63 (2003) 3855-3859
39. Westermarck J., and Kahari V.M. Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J 13 (1999) 781-792
40. Xie K., and Fidler I.J. Therapy of cancer metastasis by activation of the inducible nitric oxide synthase. Cancer Metastasis Rev 17 (1998) 55-75
41. Xie K., Huang S., Dong Z., Juang S.H., Gutman M., Xie Q.W., Nathan C., and Fidler I.J. Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis by K-1735 murine melanoma cells. J Exp Med 181 (1995) 1333-1343